BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10931214)

  • 1. Frequent presence of neuroendocrine small cells in thymic carcinoma: a light microscopic and immunohistochemical study.
    Kuo TT
    Histopathology; 2000 Jul; 37(1):19-26. PubMed ID: 10931214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.
    Hishima T; Fukayama M; Hayashi Y; Fujii T; Arai K; Shiozawa Y; Funata N; Koike M
    Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic carcinoma. A clinicopathologic study of 13 cases.
    Truong LD; Mody DR; Cagle PT; Jackson-York GL; Schwartz MR; Wheeler TM
    Am J Surg Pathol; 1990 Feb; 14(2):151-66. PubMed ID: 1689123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine Differentiation in Thymic Carcinomas: A Diagnostic Pitfall: An Immunohistochemical Analysis of 27 Cases.
    Weissferdt A; Moran CA
    Am J Clin Pathol; 2016 Mar; 145(3):393-400. PubMed ID: 27124922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
    Pan CC; Chen PC; Chou TY; Chiang H
    Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic characteristics of thymic adenocarcinomas: Clinicopathologic study of a nine-case series and a review of the literature.
    Kwon AY; Han J; Chu J; Choi YS; Jeong BH; Ahn MJ; Ahn YC
    Pathol Res Pract; 2017 Feb; 213(2):106-112. PubMed ID: 28038793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine neoplasms of the thymus.
    Wick MR; Rosai J
    Pathol Res Pract; 1988 Apr; 183(2):188-99. PubMed ID: 3290867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.
    Su XY; Wang WY; Li JN; Liao DY; Wu WL; Li GD
    Int J Clin Exp Pathol; 2015; 8(5):5354-62. PubMed ID: 26191237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.
    Walts AE; Hiroshima K; Marchevsky AM
    Ann Diagn Pathol; 2015 Aug; 19(4):216-20. PubMed ID: 25979154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms.
    Pomplun S; Wotherspoon AC; Shah G; Goldstraw P; Ladas G; Nicholson AG
    Histopathology; 2002 Feb; 40(2):152-8. PubMed ID: 11952859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?
    Bastide K; Ugolin N; Levalois C; Bernaudin JF; Chevillard S
    Lung Cancer; 2010 Apr; 68(1):1-9. PubMed ID: 20004040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine marker expression in cervical carcinomas of non-small cell type.
    Chavez-Blanco A; Taja-Chayeb L; Cetina L; Chanona-Vilchis G; Trejo-Becerril C; Perez-Cardenas E; Segura-Pacheco B; Acuña-González C; Dueñas-Gonzalez A
    Int J Gynecol Pathol; 2002 Oct; 21(4):368-74. PubMed ID: 12352185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic carcinomas: histopathological varieties and immunohistochemical study.
    Kuo TT; Chang JP; Lin FJ; Wu WC; Chang CH
    Am J Surg Pathol; 1990 Jan; 14(1):24-34. PubMed ID: 2294778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine differentiation in cervical carcinoma.
    Savargaonkar PR; Hale RJ; Mutton A; Manning V; Buckley CH
    J Clin Pathol; 1996 Feb; 49(2):139-41. PubMed ID: 8655680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratins in normal thymus and thymic epithelial tumors.
    Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
    Cancer; 1993 Jan; 71(1):99-105. PubMed ID: 7677978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation; comparison with thymic lymphoepithelioma-like carcinoma and a possibility of development from a multipotential stem cell.
    Hirokawa M; Miyauchi A; Minato H; Yokoyama S; Kuma S; Kojima M
    APMIS; 2013 Jun; 121(6):523-30. PubMed ID: 23176314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical study of small-cell and poorly differentiated carcinomas of the cervix using neuroendocrine markers.
    Ueda G; Shimizu C; Shimizu H; Saito J; Tanaka Y; Inoue M; Tanizawa O
    Gynecol Oncol; 1989 Aug; 34(2):164-9. PubMed ID: 2473948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
    Kuo TT; Chan JK
    Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.